Beth Crawford

Beth Crawford

UNVERIFIED PROFILE

Are you Beth Crawford?   Register this Author

Register author
Beth Crawford

Beth Crawford

Publications by authors named "Beth Crawford"

Are you Beth Crawford?   Register this Author

25Publications

502Reads

16Profile Views

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.

Breast Cancer Res Treat 2017 Jun 9;163(2):383-390. Epub 2017 Mar 9.

University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 2340 Sutter Street, San Francisco, CA, 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4181-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410210PMC
June 2017

Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.

Clin Breast Cancer 2016 12 5;16(6):494-499. Epub 2016 Jul 5.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2016.06.016DOI Listing
December 2016

Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.

Am J Surg Pathol 2014 Jun;38(6):793-800

Departments of *Pathology ‡Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco †Cancer Risk Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2014/06000/Association_of_
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000177DOI Listing
June 2014

Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.

Am J Surg Pathol 2014 Jun;38(6):729-42

Departments of *Pathology ‡Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco †Cancer Risk Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000199DOI Listing
June 2014

In memoriam: Dr. Charles Epstein (1933-2011). [corrected].

J Genet Couns 2011 Oct 30;20(5):429-31. Epub 2011 Jul 30.

Division of Medical Genetics, University of California Medical Center, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-011-9385-6DOI Listing
October 2011

Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.

Gynecol Oncol 2011 Aug 30;122(2):339-43. Epub 2011 Apr 30.

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.04.004DOI Listing
August 2011

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.

Int J Gynecol Cancer 2011 Jul;21(5):846-51

Cancer Risk Program, Department of Pathology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31821bc7e3DOI Listing
July 2011

Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation.

Gynecol Oncol 2011 Jun 24;121(3):466-71. Epub 2011 Feb 24.

Department of Pathology, University of California-San Francisco, 505 Parnassus Avenue, San Francisco, CA 94313, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.01.031DOI Listing
June 2011

Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.

Am J Surg Pathol 2009 Dec;33(12):1878-85

Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181bc6059DOI Listing
December 2009

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

Fam Cancer 2009 15;8(2):153-8. Epub 2008 Oct 15.

School of Medicine, University of California San Francisco, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-008-9220-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683202PMC
September 2009

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.

Genet Test Mol Biomarkers 2009 Feb;13(1):51-6

Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/gtmb.2008.0067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981359PMC
February 2009

Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.

Am J Surg Pathol 2009 Jan;33(1):111-9

Department of Pathology, Cancer Risk Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00000478-200901000-000
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e31817d74a7DOI Listing
January 2009

Development and pilot evaluation of novel genetic educational materials designed for an underserved patient population.

Genet Test 2007 ;11(3):276-90

University of California, Berkeley-University of California, San Francisco Joint Medical Program, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/gte.2007.0012DOI Listing
January 2008

Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer.

Genet Test 2006 ;10(4):281-4

Department of Neurological Surgery, UCSF Comprehensive Cancer Center, San Francisco, California 9443-0875, USA.

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/gte.2006.10.281
Publisher Site
http://dx.doi.org/10.1089/gte.2006.10.281DOI Listing
April 2007

Ductal carcinoma in situ in BRCA mutation carriers.

J Clin Oncol 2007 Feb 8;25(6):642-7. Epub 2007 Jan 8.

University of California, San Francisco Cancer Risk Program and the Carol Franc Buck Breast Care Center, San Francisco CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.0345DOI Listing
February 2007

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

J Clin Oncol 2005 Jan;23(1):127-32

Gynecologic Oncology Program and Cancer Risk Program, University of California San Francisco Comprehensive Cancer Center, 2340 Sutter Street, Room N424, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.109DOI Listing
January 2005